|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.3300 - 0.3990|
|52 Week Range||0.0060 - 0.5200|
|Beta (5Y Monthly)||-1.85|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is happy to announce the execution of an exclusive joint venture agreement with MTP MATERIAL CO. LTD. (“MTP”). This marks the first time a U.S. company has entered the Thailand cannabis industry with an agreement of this kind. MTP is a leading researcher and producer of cannabis and medical Marijuana in Thailand.
Ljubljana, Slovenia, Jan. 09, 2020 -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”. Rafarma Pharmaceuticals, Inc. is pleased to welcome a new Executive Vice-President for Thai.
RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Rafarma Pharmaceuticals, Inc. announces that following meetings this past week in Bangkok and Khon Kaen, Thailand, it has signed a Letter of Intent to acquire a 49% interest in a Thailand company which is already positioned to be a leader in the Thailand cannabis industry. Following the completion of due diligence, Rafarma will finalize its acquisition of a 49% interest (the most allowed by a foreign investor) in a local Thailand herb producer. The acquisition target, which already has decades’ experience farming, synthesizing and marketing medicinal herbs native to Thailand, has also, according to company officers, secured the necessary approvals to begin immediate cultivation for the Thai medical community as well as CBD extraction, which will then be expanded to all areas of distribution and export as applicable Thailand cannabis regulation goes into effect taking production beyond the medical industry to health spa use, and beyond..
RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. announces the cancellation of all outstanding Preferred Class A shares. On August 28th, 2019, The company’s Board of Directors unanimously voted to cancel the 30,000,000 previously-issued Class A Preferred Shares. The company’s CEO Vladimir Dolgolenko stated that the restructure of shares will better position the company to accomplish current goals for possible mergers and acquisitions with certain European and Asian companies.
RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is positioning to expand its operations in the “next big thing” in cannabis production—Thailand. Rafarma is currently in talks with Thai partners to open cannabis farms and specialized cannabis spa and detox centers in Thailand. Projected plans are to construct hemp growing greenhouses as well as a specialized spa/detox center with full-control patient living facilities the following year on approximately 1000 rai (160 hectares) in the Ranong province of Thailand.
Ljubljana, Slovenia, Aug. 22, 2019 -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is continuing to actively promote its hemp oil products in the European market. Despite.
Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Vladimir G. Dolgolenko, who resides in Slovenia, received his degrees from the Moscow State Foreign Language University (1984) and Moscow Aviation Institute (1989). Mr. Dolgolenko has earned a Masters degree in Economics and is fluent in English, Russian, Spanish and Swedish.
Rafarma Pharmaceuticals, Inc. (RAFA), is pleased to announce the commencement of negotiations with the government of the Kingdom of Thailand to use the company’s proprietary blockchain software developed by Aetsoft to manage regulatory control of the new cannabis industry in Thailand. Thailand has approved the use of cannabis and kratom plants for medicinal use only, though use of recreational cannabis remains illegal.
Rafarma Pharmaceuticals Inc (RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of the leading developers of blockchain software in the world (https://www.aetsoft.by/en/). Under the agreement Aetsoft provides Rafarma with exclusive rights to proprietary cannabis control software based on state of the art blockchain technology. Together with Aetsoft, Rafarma plans to implement the use of blockchain technologies for its own proprietary cannabis control software and will license the software for other cannabis producers & regulators around the world.
Rafarma (RAFA), a Wyoming Corporation, is pleased to announce that it has entered into a technology acquisition agreement with Dr. Yury Martirosian of Russian Academy of Scientists. Under the agreement, Rafarma is acquiring the technology and existing Eastern European patents in exchange for common stock. Rafarma plans to file International patents on the technology received in the nearest future.
RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”, a Wyoming Corporation, is pleased to announce approval of its application for farming cannabis in Slovenia through its wholly-owned subsidiary (Green Drop D.O.O.). The Application was one of only three accepted and approved by the Ministry Of Agriculture, Economy And Food Of Slovenia. This year, Rafarma will be cultivating two fields of cannabis to be used exclusively for Rafarma’s products.
Rafarma (RAFA), a Wyoming Corporation, has hired internationally acclaimed professional snowboarder Glorija Kotnik as its spokesperson and new face of the company. Ms. Kotnik is a member of the Slovenian National Snowboard Team and three-time Olympian (2010 Vancouver, 2014 Sochi and 2018 PyeongChang). With more than 120 International Ski Federation (FIS) races under her belt, she will forever be one of, if not the best, Slovenian female snowboarders of all time.